Exchange: NASDAQ·Updated 07:30 PM EDT
BBIO logo

BBIO BridgeBio Pharma Inc

$74.84
$0.57
(0.76%)
Today
Closed $74.84
$0.00
(0.00%)
After Hours
Reported EarningsAug 10
Mkt Cap$14.63B
Vol1.54M

About BBIO

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Francis Patrick McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.
42

Bearish Sentiment

How do you feel about BBIO?

Advertisement|Remove ads.